Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Identification and Validation of Molecular Markers of Tumor Cell Resistance to Natural Killer Cells through CRISPR-Based Screens and Large-Scale Phenotypic Screens of Pooled Tumor Cell Lines

Michal Sheffer, PhD, Lotte Wieten, PhD, Channing Yu, MD PhD, Yiguo Yu, PhD, Olga Dashevsky, PhD, Emily Lowry, Jennifer Roth, Aviad Tsherniak, PhD, Chris C Mader, Sam Bender, Jordan Bryan, Cong Zhu, Li Wang, Ricardo De Matos Simoes, PhD, Sara Gandolfi, MD, Eugen Dhimolea, PhD, Megan Bariteau, Todd R. Golub, MD, Constantine S. Mitsiades, MD PhD

Blood (2017) 130 (Supplement 1): 623.

https://doi.org/10.1182/blood.V130.Suppl_1.623.623

Published: 2017

Journal Articles

Developmental Stage-Selective Effect of Somatically Mutated GATA-1 in Down Syndrome AML M7--a Potential Basis for Transient Myeloproliferative Disorder.

Zhe Li, PhD, Frank Godinho, BS, Mireia Garriga-Canut, PhD, Channing Yu, PhD, Stuart H. Orkin, MD

Blood (2004) 104 (11): 463.

https://doi.org/10.1182/blood.V104.11.463.463

Published: 2004

Journal Articles

X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction

Channing Yu, Kathy K. Niakan, Mark Matsushita, George Stamatoyannopoulos, Stuart H. Orkin, Wendy H. Raskind

Blood (2002) 100 (6): 2040–2045.

https://doi.org/10.1182/blood-2002-02-0387

Published: 2002

Journal Articles

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding

Pu Zhang, Xiaobo Zhang, Atsushi Iwama, Channing Yu, Kent A. Smith, Beatrice U. Mueller, Salaija Narravula, Bruce E. Torbett, Stuart H. Orkin, Daniel G. Tenen

Blood (2000) 96 (8): 2641–2648.

https://doi.org/10.1182/blood.V96.8.2641

Published: 2000

Journal Articles

GATA-1 and Erythropoietin Cooperate to Promote Erythroid Cell Survival by Regulating bcl-x L Expression

Todd Gregory, Channing Yu, Averil Ma, Stuart H. Orkin, Gerd A. Blobel, Mitchell J. Weiss

Blood (1999) 94 (1): 87–96.

https://doi.org/10.1182/blood.V94.1.87.413k41_87_96

Published: 1999

NARROW

Identification and Validation of Molecular Markers of Tumor Cell Resistance to Natural Killer Cells through CRISPR-Based Screens and Large-Scale Phenotypic Screens of Pooled Tumor Cell Lines

Developmental Stage-Selective Effect of Somatically Mutated GATA-1 in Down Syndrome AML M7--a Potential Basis for Transient Myeloproliferative Disorder.

X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding

GATA-1 and Erythropoietin Cooperate to Promote Erythroid Cell Survival by Regulating bcl-x L Expression

Email alerts

ASH Publications

American Society of Hematology

Identification and Validation of Molecular Markers of Tumor Cell Resistance to Natural Killer Cells through CRISPR-Based Screens and Large-Scale Phenotypic Screens of Pooled Tumor Cell Lines

Developmental Stage-Selective Effect of Somatically Mutated GATA-1 in Down Syndrome AML M7--a Potential Basis for Transient Myeloproliferative Disorder.

X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding

GATA-1 and Erythropoietin Cooperate to Promote Erythroid Cell Survival by Regulating bcl-x L Expression

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only